Dimenhydrinate, also known as Dramamine or Gravol, is an over-the-counter drug used to prevent nausea, vomiting, and dizziness caused by motion sickness.
Market Analysis and Insights: Global Dimenhydrinate Market
Due to the COVID-19 pandemic, the global Dimenhydrinate market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Oral accounting for % of the Dimenhydrinate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Dimenhydrinate market size is valued at US$ million in 2021, while the US and Europe Dimenhydrinate are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Dimenhydrinate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Dimenhydrinate include Bristol-Myers Squibb, Baxter Healthcare, Watson Laboratories, Pfizer, Nexgen Pharma, Goodwill Pharma, Hennig Arzneimittel, Zambon and Apotex, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Dimenhydrinate Scope and Segment
Dimenhydrinate market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Dimenhydrinate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Oral
Injection
Segment by Application
Hospital
Drug Store
On-line
By Company
Bristol-Myers Squibb
Baxter Healthcare
Watson Laboratories
Pfizer
Nexgen Pharma
Goodwill Pharma
Hennig Arzneimittel
Zambon
Apotex
Teva
Mylan
Cinfa
Neuraxpharm Arzneimittel
Gedeon Richter
Medrock Biotech
Strides Pharma
Fresenius
Novartis
Johnson and Johnson
Yoshindo
IFET
Bayer
Nidda Healthcare
Medifarma
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE